Randi Hagerman
Medical Director
MIND Institute
From this contributor
Diabetes drug delivers multiple benefits for people with fragile X syndrome
Researcher Randi Hagerman is a big proponent of metformin — a diabetes drug that she is testing in people with fragile X syndrome. In fact, Hagerman takes the drug herself as a preventive measure against cancer.
Diabetes drug delivers multiple benefits for people with fragile X syndrome
Drug trials for fragile X syndrome lead the way for autism
Several targeted trials on drugs that treat fragile X syndrome are under way. But accurate endpoints to measure the drugs’ effectiveness are crucial, argues developmental and behavioral pediatrician Randi Hagerman.
Drug trials for fragile X syndrome lead the way for autism
Explore more from The Transmitter
Single gene sways caregiving circuits, behavior in male mice
Brain levels of the agouti gene determine whether African striped mice are doting fathers—or infanticidal ones.
Single gene sways caregiving circuits, behavior in male mice
Brain levels of the agouti gene determine whether African striped mice are doting fathers—or infanticidal ones.
Inner retina of birds powers sight sans oxygen
The energy-intensive neural tissue relies instead on anaerobic glucose metabolism provided by the pecten oculi, a structure unique to the avian eye.
Inner retina of birds powers sight sans oxygen
The energy-intensive neural tissue relies instead on anaerobic glucose metabolism provided by the pecten oculi, a structure unique to the avian eye.
Neuroscience needs single-synapse studies
Studying individual synapses has the potential to help neuroscientists develop new theories, better understand brain disorders and reevaluate 70 years of work on synaptic transmission plasticity.
Neuroscience needs single-synapse studies
Studying individual synapses has the potential to help neuroscientists develop new theories, better understand brain disorders and reevaluate 70 years of work on synaptic transmission plasticity.